MichaelMorrisMD

Clinical Trials

• Calcitriol and Zoledronate in Treating Patients With Progressive Prostate Cancer Start of enrollment: 1999 Oct 01

  Completed

  Phase 1

• Testosterone in Treating Patients With Progressive Prostate Cancer That No Longer Responds to Hormone Therapy Start of enrollment: 2000 Feb 01

  Completed

  Phase 1

• Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2001 Jun 01

  Completed

  Phase 2

• Ixabepilone With or Without Estramustine in Treating Patients With Progressive Prostate Cancer Start of enrollment: 2001 Jul 01

  Completed

  Phase 1, Phase 2

• Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer Start of enrollment: 2005 Jul 01

  Unknown status

  Phase 1, Phase 2

• [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer Start of enrollment: 2003 Feb 01

  Recruiting

  Not Applicable

• Alpharadin™ (Radium-223 Chloride) Safety and Dosimetry With HRPC That Has Metastasized to the Skeleton Start of enrollment: 2008 Aug 01

  Completed

  Phase 1

• Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate Cancer Start of enrollment: 2009 Mar 01

  Completed

  Phase 2

• Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancer Start of enrollment: 2011 Feb 01

  Unknown status

  Phase 2

• Sodium Fluoride (NaF) Positron Emission Tomography/Computed Tomography (PET/CT) in Patients With Metastatic Castrate-resistant Prostate Cancer (CRPC) With Microtubule Directed Chemo or AR-directed Therapy Start of enrollment: 2011 Nov 01

  Completed

• Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer Start of enrollment: 2012 Jun 01

  Withdrawn

• Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer Start of enrollment: 2014 Jan 22

  Active, not recruiting

  Phase 3

• Use of an Experimental Radiopharmaceutical (131I-MIP-1095) in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Start of enrollment: 2017 Jan 19

  Completed

  Phase 1

• A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer Start of enrollment: 2018 Jun 19

  Recruiting

  Phase 3

• Safety and Targeting of Anti-hk2 Antibody in mCRPC Start of enrollment: 2019 Sep 18

  Terminated

  Early Phase 1

• A Study of Stereotactic Body Radiation Therapy and Radium (Ra-223) Dichloride in Prostate Cancer That Has Spread to the Bones Start of enrollment: 2021 Nov 12

  Recruiting

  Phase 2

  Roles: Contact

• Safety Study of a Radiolabeled Antibody (7E11) in Patients With Progressive Hormone Refractory Prostate Cancer Start of enrollment: 2007 Feb 01

  Unknown status

  Phase 1

  Roles: Contact, Principal Investigator

• Join now to see all